MFN2 and chronic obstructive pulmonary disease: It has been shown that MFN2 and OPA1 are downregulated in COPD, whereas increasing MFN2 and OPA1 expression can somehow attenuate oxidative stress and cellular senescence (Li et al., 2023; Maremanda et al., 2021).